🇺🇸 FDA
Patent

US 12384797

Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia

granted A61PA61P25/00

Quick answer

US patent 12384797 (Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia) held by PTC THERAPEUTICS, INC. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P25/00